For the first time in more than a century, the world may finally be getting a new shield against tuberculosis — and South Africa is racing to be ready for it the moment it arrives.
The Department of Health is putting plans in place so South Africans can get the new M72/AS01E vaccine as soon as possible if the final trials succeed. The vaccine is being tested right now in five countries: South Africa, Kenya, Zambia, Malawi and Indonesia. Its aim is to stop TB from taking hold in teenagers and adults — the people the current vaccine barely helps.
To understand why this matters, you have to know the old vaccine's limits. The only TB shot currently available is called BCG, and it has been around for more than 100 years. Doctors give it to newborn babies and children under five. It works well at protecting little ones, but its power fades as people grow up. That leaves millions of teenagers and adults vulnerable to a disease that still ranks among the world's deadliest infectious killers.
South Africa carries one of the heaviest TB burdens of any country, so the news hit close to home. Department spokesperson Foster Mohale called the breakthrough "arguably a major step toward a new TB vaccine, the first significant advance since BCG more than 100 years ago."
Behind the scenes, a powerful team has been assembling. Officials from the Gates Medical Research Institute and the Bill & Melinda Gates Foundation told the department that a deal had been struck with the Serum Institute of India — the largest vaccine maker on the planet — to produce and supply the doses worldwide. And the agreement goes even further: it allows pharmaceutical partners in South Africa and Indonesia to gradually start making the vaccine themselves, which could boost their economies and create jobs.
Before anyone can roll up their sleeve, the vaccine must pass its phase three trials and get a green light from the South African Health Products Regulatory Authority, known as SAHPRA. Mohale made clear the department is not waiting around. "To ensure we can offer protection to South Africans at the earliest opportunity if the trial is successful, the Department of Health is proactively preparing for registration and introduction of the new vaccine," he said.
The stakes are high, and the country has set an ambitious goal: eliminating TB as a public health threat by 2030. A vaccine that finally protects adults would be a giant step toward reaching that target — and toward a future where a disease that has haunted humanity for millennia begins to loosen its grip.
For now, the world holds its breath and watches the trial results. If they come back positive, South Africa intends to be first in line — ready to turn a century-old scientific promise into a real shot of hope.